Cyclo Therapeutics (CYTH) Institutional Ownership $0.63 +0.01 (+1.61%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cyclo Therapeutics (NASDAQ:CYTH)CurrentInstitutional OwnershipPercentage68.55%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$939.26KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$46.41K Get CYTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CYTH Institutional Buying and Selling by Quarter Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Cyclo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/10/2024 EPIQ Capital Group LLC817,270$1.04M0.4%-4.3%2.856% 2/15/2024 Founders Fund V Management LLC480,708$764K80.8%N/A2.115% 2/15/2024 Founders Fund VI Management LLC110,023$175K1.4%N/A0.484% 11/9/2021BlackRock Inc.13,134$88K0.0%+21.1%0.204% 8/16/2021 State Street Corp44,700$457K0.0%N/A0.703% 8/13/2021 Geode Capital Management LLC42,577$435K0.0%+133.2%0.670% 8/13/2021 Vanguard Group Inc.151,540$1.55M0.0%+350.4%2.383% 5/12/2021 Geode Capital Management LLC18,257$149K0.0%N/A0.287% 3/26/2021 Susquehanna International Group LLP15,656$68K0.0%N/A0.249% 2/17/2021 Jane Street Group LLC27,892$121K0.0%N/A1.641% 2/17/2021 Worth Venture Partners LLC88,690$386K0.3%N/A5.217% 2/16/2021 Armistice Capital LLC100,000$435K0.0%N/A5.882% (Data available from 1/1/2016 forward) CYTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CYTH shares? During the previous two years, the following institutional investors and hedge funds held shares of Cyclo Therapeutics shares: EPIQ Capital Group LLC ($1.04M), and Founders Fund V Management LLC ($764K), Founders Fund VI Management LLC ($175K).Learn more on CYTH's institutional investors. What percentage of Cyclo Therapeutics stock is owned by institutional investors? 68.55% of Cyclo Therapeutics stock is owned by institutional investors. Learn more on CYTH's institutional investor holdings. Which institutional investors have been buying Cyclo Therapeutics stock? The following institutional investors have purchased Cyclo Therapeutics stock in the last 24 months: Founders Fund V Management LLC ($480.71K), and Founders Fund VI Management LLC ($110.02K). How much institutional buying is happening at Cyclo Therapeutics? Institutional investors have bought a total of 590,731 shares in the last 24 months. This purchase volume represents approximately $939.26K in transactions. Which Cyclo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cyclo Therapeutics stock in the last 24 months: EPIQ Capital Group LLC ($36.55K). How much institutional selling is happening at Cyclo Therapeutics? Institutional investors have sold a total of 36,545 shares in the last 24 months. This volume of shares sold represents approximately $46.41K in transactions. Related Companies VHAQ Major Shareholders BCAB Major Shareholders CUE Major Shareholders SLS Major Shareholders OSTX Major Shareholders INCR Major Shareholders DBVT Major Shareholders ONCY Major Shareholders BYSI Major Shareholders VNRX Major Shareholders This page (NASDAQ:CYTH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTH Stock Alerts